ACE Report Cover
Noninferiority of low-intensity to standard-intensity warfarin in geriatric hip or knee arthroplasty
Language
Download
Cite
+ Favorites
Language
Download
Cite
+ Favorites
AceReport Image
ARTHROPLASTY
Noninferiority of low-intensity to standard-intensity warfarin in geriatric hip or knee arthroplasty .

Effect of Low-Intensity vs Standard-Intensity Warfarin Prophylaxis on Venous Thromboembolism or Death Among Patients Undergoing Hip or Knee Arthroplasty: A Randomized Clinical Trial

JAMA. 2019 Sep 3;322(9):834-842.

1650 elderly patients undergoing a hip or knee arthroplasty were randomized to receive a low-intensity dose (International Normalized Ratio (INR) = 1.8) or standard-intensity dose (INR = 2.5) of warfarin for the prevention of thromboembolic events. The primary outcome of interest was the composite outcome of VTE and death. Secondary outcomes of interest included the rate of major bleeding and the proportion of patients with a INR greater or equal to 4. Follow up was performed for up to 90 days post-surgery. The results revealed no significant difference between groups in the composite outcome of VTE and death, however this did not meet the criteria for non-inferiority. No significant difference in the rate of major bleeding was observed between the two groups. The proportion of patients with INR => 4 was significantly higher in the standard-intensity warfarin group.

Unlock the Full ACE Report

You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or upgrade today and gain access to all OrthoEvidence
content for as little as $1.99 per week.
0 of 4 monthly FREE articles unlocked
You've reached your limit of 4 free articles views this month

Access to OrthoEvidence for as little as $1.99 per week.

Stay connected with latest evidence. Cancel at any time.
  • Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
  • Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
  • Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Upgrade
Welcome Back!
Forgot Password?
Start your FREE trial today!

Account will be affiliated with


OR
Forgot Password?

OR
Please check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see an email, please check your spam or junk folder.

For further assistance, contact our support team.

Translate ACE Report

OrthoEvidence utilizes a third-party translation service to make content accessible in multiple languages. Please note that while every effort is made to ensure accuracy, translations may not always be perfect.

Cite this ACE Report

OrthoEvidence. Noninferiority of low-intensity to standard-intensity warfarin in geriatric hip or knee arthroplasty. ACE Report. 2019;8(12):3. Available from: https://myorthoevidence.com/AceReport/Show/noninferiority-of-low-intensity-to-standard-intensity-warfarin-in-geriatric-hip-or-knee-arthroplasty

Copy Citation
Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Premium Member Feature

To access this feature, you must be logged into a premium OrthoEvidence account.

Share this ACE Report